Regardless of p53 status, we demonstrated a pronounced cytotoxic effect in all five primary glioblastoma cultures after treatment with TTFields and a low effective dose of AZD1152, supporting our data from the analysis of U87-MG and U87-MGshp53 cells. This evidence concerns the gene TP53 and glioblastoma.